Apolipoprotein E Genotype Is Associated With CT Angiography Spot Sign in Lobar Intracerebral Hemorrhage
Open Access
- 1 August 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 43 (8), 2120-2125
- https://doi.org/10.1161/strokeaha.112.659094
Abstract
Background and Purpose—: The CT angiography (CTA) spot sign predicts hematoma expansion and poor outcome in patients with primary intracerebral hemorrhage (ICH). The biological underpinnings of the spot sign remain poorly understood; it may be that the underlying vasculopathy influences its presence. Therefore, we conducted a study to identify genetic predictors of the spot sign. Methods—: In an ongoing prospective cohort study, we analyzed 371 patients with CTA and genetic data available. CTAs were reviewed for the spot sign by 2 experienced readers, blinded to clinical data, according to validated criteria. Analyses were stratified by ICH location. Results—: In multivariate analysis, patients on warfarin were more likely to have a spot sign regardless of ICH location (OR, 3.85; 95% CI, 1.33–11.13 in deep ICH and OR, 2.86; 95% CI, 1.33–6.13 in lobar ICH). Apolipoprotein E ϵ2, but not ϵ4, was associated with the presence of a spot sign in lobar ICH (OR, 2.09; 95% CI, 1.05–4.19). There was no effect for ϵ2 or ϵ4 in deep ICH. Conclusions—: Patients with ICH on warfarin are more likely to present with a spot sign regardless of ICH location. Among patients with lobar ICH, those who possess the apolipoprotein E ϵ2 allele are more likely to have a spot sign. Given the established relationship between apolipoprotein E ϵ2 and vasculopathic changes in cerebral amyloid angiopathy, our findings suggest that both hemostatic factors and vessel pathology influence spot sign presence.This publication has 24 references indexed in Scilit:
- Apolipoprotein E Genotype Predicts Hematoma Expansion in Lobar Intracerebral HemorrhageStroke, 2012
- Contrast Extravasation on Computed Tomography Angiography Predicts Clinical Outcome in Primary Intracerebral HemorrhageStroke, 2011
- APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association studyLancet Neurology, 2011
- Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: Design, Methods, and RationaleNeurocritical Care, 2011
- Defining hematoma expansion in intracerebral hemorrhageNeurology, 2011
- Variants at APOE Influence Risk of Deep and Lobar Intracerebral HemorrhageAnnals of Neurology, 2010
- The Spot Sign Score in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk of In-Hospital Mortality and Poor Outcome Among SurvivorsStroke, 2010
- Systematic Characterization of the Computed Tomography Angiography Spot Sign in Primary Intracerebral Hemorrhage Identifies Patients at Highest Risk for Hematoma ExpansionStroke, 2009
- Cerebral microbleeds: a guide to detection and interpretationThe Lancet Neurology, 2009
- Early Hemorrhage Growth in Patients With Intracerebral HemorrhageStroke, 1997